← Leaderboards
Michael Francis Beers
University Of Pennsylvania
$18,247,357
Attributed
$18,247,357
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,247,357 · 11
VA$0 · 2
By mechanism
R01$12,748,385 · 6
U01$2,974,500 · 1
P01$2,347,221 · 2
S10$152,251 · 1
R13$25,000 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Michael S Marks$18,307,737
- Dejian Ren$10,845,009
- Surafel Mulugeta$3,909,502
- Megan Kathleen Dennis$659,085
- Edward E Morrisey$54,694,196
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCellsFundingPathway InteractionsPathogenesisProgramsIn VivoEpithelial CellsFunctional DisorderAlveolarResponseIn VitroMouse ModelMutantMutationRespiratory FailureInterstitial Lung DiseasesDistalPublishingMolecularAffectPulmonary Surfactant-Associated Protein CLung DiseasesGenes
Grant awards (62)
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$650,442
R01 · FY2025 · HL · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$223,438
R01 · FY2025 · HL · contact PI
Surfactant Protein C Mouse Models: A Fit For Purpose Preclinical Platform For Advancing Discovery In And Treatment Of Idiopathic Pulmonary Fibrosis$765,307
U01 · FY2024 · HL · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$666,067
R01 · FY2024 · HL · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2024 · VA · contact PI
Surfactant Protein C Mouse Models: A Fit For Purpose Preclinical Platform For Advancing Discovery In And Treatment Of Idiopathic Pulmonary Fibrosis$791,466
U01 · FY2023 · HL · contact PI
COVID-19: Understanding The Role of Corona Virus InducedDisruption Of Alveolar Type 2 Cell Function And SurfactantHomeostasis In The Pathogenesis Of COVID-19 AcuteRespiratory Distress Syndrome$0
I01 · FY2023 · VA · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2023 · VA · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2023 · VA · contact PI
Surfactant Protein C Mouse Models: A Fit For Purpose Preclinical Platform For Advancing Discovery In And Treatment Of Idiopathic Pulmonary Fibrosis$801,387
U01 · FY2022 · HL · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$551,525
R01 · FY2022 · HL · contact PI
COVID-19: Understanding The Role of Corona Virus InducedDisruption Of Alveolar Type 2 Cell Function And SurfactantHomeostasis In The Pathogenesis Of COVID-19 AcuteRespiratory Distress Syndrome$0
I01 · FY2022 · VA · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2022 · VA · contact PI
Surfactant Protein C Mouse Models: A Fit For Purpose Preclinical Platform For Advancing Discovery In And Treatment Of Idiopathic Pulmonary Fibrosis$616,340
U01 · FY2021 · HL · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$551,383
R01 · FY2021 · HL · contact PI
COVID-19: Understanding The Role of Corona Virus InducedDisruption Of Alveolar Type 2 Cell Function And SurfactantHomeostasis In The Pathogenesis Of COVID-19 AcuteRespiratory Distress Syndrome$0
I01 · FY2021 · VA · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2021 · VA · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$549,828
R01 · FY2020 · HL · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2020 · VA · contact PI
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets$549,546
R01 · FY2019 · HL · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2019 · VA · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2018 · VA · contact PI
Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease$402,250
R01 · FY2017 · HL · contact PI
Surfactant Protein C Mutations and Interstitial Lung Disease$0
I01 · FY2017 · VA · contact PI
Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease$402,250
R01 · FY2016 · HL · contact PI
Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease$396,216
R01 · FY2015 · HL · contact PI
Surfactant protein C mutations and interstitial lung diease$0
I01 · FY2015 · VA · contact PI
Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease$394,205
R01 · FY2014 · HL · contact PI
Surfactant protein C mutations and interstitial lung diease$0
I01 · FY2014 · VA · contact PI
Biosynthesis and Trafficking of Surfactant Protein C In Health and Disease$390,939
R01 · FY2013 · HL · contact PI
Surfactant protein C mutations and interstitial lung diease$0
I01 · FY2013 · VA · contact PI
Surfactant protein C mutations and interstitial lung diease$0
I01 · FY2012 · VA · contact PI
Post-translational Processing of Surfactant Protein C$390,276
P01 · FY2011 · HL · contact PI
Typhoon 9400 Variable Mode Imager for Quantitative Detection of Biomolecules$152,251
S10 · FY2011 · RR · contact PI
Post-translational Processing of Surfactant Protein C$390,277
P01 · FY2010 · HL · contact PI
Expression and function of ABCA3 in type 2 cells$326,442
R01 · FY2010 · HL · contact PI
FASEB Summer Research Conference titled "THE LUNG EPITHELIUM IN HEALTH AND DISEAS$25,000
R13 · FY2010 · HL · contact PI
Post-translational Processing of Surfactant Protein C$406,370
P01 · FY2009 · HL · contact PI
Models of P. carinii Infection: SP-A and SP-D null mice$364,562
R01 · FY2009 · HL · contact PI
Expression and function of ABCA3 in type 2 cells$317,490
R01 · FY2009 · HL · contact PI
Post-translational Processing of Surfactant Protein C$406,370
P01 · FY2008 · HL · contact PI
Models of P. carinii infections SP-A and SP-D null mice$364,562
R01 · FY2008 · HL · contact PI
Expression and function of ABCA3 in type 2 cells$308,702
R01 · FY2008 · HL · contact PI
Post-translational Processing of Surfactant Protein C$420,939
P01 · FY2007 · HL · contact PI
Models of P. carinii infections SP-A and SP-D null mice$364,562
R01 · FY2007 · HL · contact PI
Surfactant Protein C Mutations:Interstitial Lung Disease$517,256
R01 · FY2006 · HL · contact PI
Models of P Carinii Infection: SP-A and SP-D Null Mice$363,603
R01 · FY2006 · HL · contact PI
Surfactant Protein C Mutations:Interstitial Lung Disease$396,250
R01 · FY2005 · HL
Models of P Carinii Infection: SP-A and SP-D Null Mice$386,513
R01 · FY2005 · HL
Surfactant Protein C Mutations:Interstitial Lung Disease$133,450
R01 · FY2005 · HL
Surfactant Protein C Mutations:Interstitial Lung Disease$390,400
R01 · FY2004 · HL
Surfactant Protein C Mutations:Interstitial Lung Disease$390,400
R01 · FY2003 · HL
MODELS OF P CARINII INFECTION: SP-A AND SP-D NULL MICE$356,625
R01 · FY2003 · HL
MODELS OF P CARINII INFECTION: SP-A AND SP-D NULL MICE$356,625
R01 · FY2002 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$333,424
R01 · FY2002 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$282,412
P01 · FY2002 · RR
MODELS OF P CARINII INFECTION: SP-A AND SP-D NULL MICE$356,625
R01 · FY2001 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$327,489
R01 · FY2001 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$0
P01 · FY2001 · RR
MODELS OF P CARINII INFECTION: SP-A AND SP-D NULL MICE$344,925
R01 · FY2000 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$320,391
R01 · FY2000 · HL
SURFACTANT METABOLISM IN PNEUMOCYSTIS CARINII PNEUMONIA$50,577
P01 · FY2000 · RR